Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · IEX Real-Time Price · USD
438.81
+2.57 (0.59%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Intuitive Surgical Market Cap
Intuitive Surgical has a market cap or net worth of $155.65 billion as of July 2, 2024. Its market cap has increased by 35.73% in one year.
Market Cap
155.65B
Enterprise Value
150.85B
1-Year Change
35.73%
Ranking
Category
Stock Price
$438.81
Market Cap Chart
Since June 16, 2000, Intuitive Surgical's market cap has increased from $314.50M to $155.65B, an increase of 49,390.79%. That is a compound annual growth rate of 29.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 154.74B | 30.28% |
Dec 29, 2023 | 118.77B | 26.67% |
Dec 30, 2022 | 93.77B | -26.94% |
Dec 31, 2021 | 128.36B | 33.46% |
Dec 31, 2020 | 96.17B | 40.76% |
Dec 31, 2019 | 68.32B | 24.92% |
Dec 31, 2018 | 54.69B | 33.75% |
Dec 29, 2017 | 40.89B | 66.41% |
Dec 30, 2016 | 24.57B | 20.41% |
Dec 31, 2015 | 20.41B | 6.43% |
Dec 31, 2014 | 19.18B | 31.16% |
Dec 31, 2013 | 14.62B | -25.02% |
Dec 31, 2012 | 19.50B | 8.00% |
Dec 30, 2011 | 18.05B | 78.27% |
Dec 31, 2010 | 10.13B | -12.60% |
Dec 31, 2009 | 11.59B | 133.30% |
Dec 31, 2008 | 4.97B | -59.75% |
Dec 31, 2007 | 12.34B | 248.28% |
Dec 29, 2006 | 3.54B | -14.82% |
Dec 30, 2005 | 4.16B | 205.79% |
Dec 31, 2004 | 1.36B | 147.12% |
Dec 31, 2003 | 550.50M | 144.12% |
Dec 31, 2002 | 225.50M | -37.90% |
Dec 31, 2001 | 363.10M | 19.72% |
Dec 29, 2000 | 303.30M | -3.56% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Thermo Fisher | 203.81B |
Abbott Laboratories | 179.53B |
Danaher | 178.07B |
Amgen | 166.71B |
Pfizer | 157.70B |
Stryker | 127.35B |
Elevance Health | 124.56B |
Vertex Pharmaceuticals | 122.26B |